NEW YORK, July 18, 2017 -- Greystone, a real estate lending, investment and advisory company, announced it has provided a $17,250,000 bridge loan to finance the acquisition of The Pavilions at Monterey in Palm Bay, FL. The transaction was originated by Leor Dimant of Greystone’s New York office.
Carabetta Companies, one of the largest HUD borrowers, purchased The Pavilions at Monterey on June 29 for $20,650,000. The two-year bridge loan from Greystone, at 83.5% loan-to-purchase, provides time for Carabetta to rehabilitate and stabilize the property while concurrently securing a low, fixed-rate, permanent loan from HUD with Greystone.
The Pavilions at Monterey is a 271-unit Class B property offering many amenities to residents including a fitness center and swimming pool. It is located on the southeast coast of Florida, within proximity of Florida Institute of Technology.
“Our portfolio lending platform provides tremendous flexibility. Greystone helps owners navigate the tenuous acquisition process, including a seamless transition to long-term debt with our proprietary FHA program,” said Mr. Fred Levine, Managing Director, Greystone.
“Greystone’s ability to work with our leverage requirement and their attention to detail are the invaluable components that made this work,” said Sam Carabetta, principal, Carabetta Companies.
About Greystone
Greystone is a real estate lending, investment and advisory company with an established reputation as a leader in multifamily and healthcare finance, having ranked as a top FHA and Fannie Mae lender in these sectors. Our range of services includes commercial lending across a variety of platforms such as Fannie Mae, Freddie Mac, CMBS, FHA, USDA, bridge and proprietary loan products. Loans are offered through Greystone Servicing Corporation, Inc., Greystone Funding Corporation and/or other Greystone affiliates. For more information, visit www.greyco.com.
PRESS CONTACT: Karen Marotta Greystone 212-896-9149 [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
First Western Ship Transits Strait of Hormuz Since Iran War Began
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 



